65 related articles for article (PubMed ID: 1328848)
41. Specific selection of deoxycytidine kinase mutants with tritiated deoxyadenosine.
Chan TS; Nelson JA
Biochem Genet; 1995 Oct; 33(9-10):327-40. PubMed ID: 8748457
[TBL] [Abstract][Full Text] [Related]
42. Novel mutants of CHO cells resistant to adenosine analogs and containing biochemically altered form of adenosine kinase in cell extracts.
Mehta KD; Gupta RS
Somat Cell Mol Genet; 1986 Jan; 12(1):21-31. PubMed ID: 3003929
[TBL] [Abstract][Full Text] [Related]
43. The metabolism of 3'-azido-2',3'-dideoxyguanosine in CEM cells.
Karlsson A; Reichard P; Eckstein F
Biochem Biophys Res Commun; 1990 Jan; 166(1):273-9. PubMed ID: 2405846
[TBL] [Abstract][Full Text] [Related]
44. Use of nucleoside kinase-deficient mouse leukemia L1210 cell lines to determine metabolic routes of activation of antitumor nucleoside analogs.
Cory AH; Cory JG
Adv Enzyme Regul; 1994; 34():1-12. PubMed ID: 7942266
[TBL] [Abstract][Full Text] [Related]
45. Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells.
Innoceta A; Galluzzi L; Ruzzo A; Andreoni F; Chiarantini L; Magnani M
Mol Cell Biochem; 2002 Feb; 231(1-2):173-7. PubMed ID: 11952160
[TBL] [Abstract][Full Text] [Related]
46. Adenosine kinase-deficient mutant of Saccharomyces cerevisiae.
Iwashima A; Ogata M; Nosaka K; Nishimura H; Hasegawa T
FEMS Microbiol Lett; 1995 Mar; 127(1-2):23-8. PubMed ID: 7737480
[TBL] [Abstract][Full Text] [Related]
47. Novel role of 3-phosphoglycerate kinase, a glycolytic enzyme, in the activation of L-nucleoside analogs, a new class of anticancer and antiviral agents.
Krishnan P; Gullen EA; Lam W; Dutschman GE; Grill SP; Cheng YC
J Biol Chem; 2003 Sep; 278(38):36726-32. PubMed ID: 12869554
[TBL] [Abstract][Full Text] [Related]
48. Population pharmacodynamic modeling of drug-induced anemia.
Ganes D; Bansal S; Johnson D; Leal M; Nicolau G; Yacobi A
J Pharm Sci; 1993 May; 82(5):546-9. PubMed ID: 8360835
[No Abstract] [Full Text] [Related]
49. Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases.
Johansson NG; Eriksson S
Acta Biochim Pol; 1996; 43(1):143-60. PubMed ID: 8790720
[TBL] [Abstract][Full Text] [Related]
50. Human and viral nucleoside/nucleotide kinases involved in antiviral drug activation: structural and catalytic properties.
Deville-Bonne D; El Amri C; Meyer P; Chen Y; Agrofoglio LA; Janin J
Antiviral Res; 2010 Apr; 86(1):101-20. PubMed ID: 20417378
[TBL] [Abstract][Full Text] [Related]
51. Metabolic pathways for the activation of the antiviral agent 2',3'-dideoxyguanosine in human lymphoid cells.
Bondoc LL; Ahluwalia G; Cooney DA; Hartman NR; Johns DG; Fridland A
Mol Pharmacol; 1992 Sep; 42(3):525-30. PubMed ID: 1328848
[TBL] [Abstract][Full Text] [Related]
52. Tiazofurin metabolism in human lymphoblastoid cells: evidence for phosphorylation by adenosine kinase and 5'-nucleotidase.
Fridland A; Connelly MC; Robbins TJ
Cancer Res; 1986 Feb; 46(2):532-7. PubMed ID: 3000575
[TBL] [Abstract][Full Text] [Related]
53. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
Verhoef V; Sarup J; Fridland A
Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
[TBL] [Abstract][Full Text] [Related]
54. Phosphorylation of 2',3'-dideoxyinosine by cytosolic 5'-nucleotidase of human lymphoid cells.
Johnson MA; Fridland A
Mol Pharmacol; 1989 Aug; 36(2):291-5. PubMed ID: 2549385
[TBL] [Abstract][Full Text] [Related]
55. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
56. Metabolism of the carbocyclic nucleoside analogue carbovir, an inhibitor of human immunodeficiency virus, in human lymphoid cells.
Bondoc LL; Shannon WM; Secrist JA; Vince R; Fridland A
Biochemistry; 1990 Oct; 29(42):9839-43. PubMed ID: 2271622
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
